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Abstract Multimarker transmission/disequilibrium tests
(TDTs) are powerful association and linkage tests used to
perform genome-wide ﬁltering in the search for disease
susceptibility loci. In contrast to case/control studies, they
have a low rate of false positives for population stratiﬁ-
cation and admixture. However, the length of a region
found in association with a disease is usually very large
because of linkage disequilibrium (LD). Here, we deﬁne a
multimarker proportional TDT (mTDTP) designed to
improve locus speciﬁcity in complex diseases that has good
power compared to the most powerful multimarker TDTs.
The test is a simple generalization of a multimarker TDT in
which haplotype frequencies are used to weight the effect
that each haplotype has on the whole measure. Two con-
cepts underlie the features of the metric: the ‘common
disease, common variant’ hypothesis and the decrease in
LD with chromosomal distance. Because of this decrease,
the frequency of haplotypes in strong LD with common
disease variants decreases with increasing distance from
the disease susceptibility locus. Thus, our haplotype pro-
portional test has higher locus speciﬁcity than common
multimarker TDTs that assume a uniform distribution of
haplotype probabilities. Because of the common variant
hypothesis, risk haplotypes at a given locus are relatively
frequent and a metric that weights partial results for each
haplotype by its frequency will be as powerful as the most
powerful multimarker TDTs. Simulations and real data sets
demonstrate that the test has good power compared with
the best tests but has remarkably higher locus speciﬁcity, so
that the association rate decreases at a higher rate with
distance from a disease susceptibility or disease protective
locus.
Introduction
Genome-wide genotyping of single-nucleotide polymor-
phisms (SNPs) can yield a few hundred thousand binary
markers in a single chip array, providing a relatively
unbiased examination of the entire genome for common
risk variants. Many loci have been determined to be
associated with multifactorial diseases using this new
technology. However, in most cases, the information pro-
vided is not enough to localize the causal variant of the
association. Nonetheless, genome-wide association studies
yield useful information for better identiﬁcation of an
associated region that facilitates ﬁne mapping of the region
with a reduced number of markers.
There are two main types of genome-wide data associ-
ation analyses: case–control studies and family-based
studies. Although case–control association studies are the
most common, they have high type I errors because of
population stratiﬁcation (Spielman et al. 1993; Zhang et al.
2003). In family-based studies, transmission/disequilibrium
tests (TDTs) are powerful tests requiring only family trios
with both parents and one affected offspring. In contrast to
case–control studies, TDTs are known to be robust for
population structures. Therefore, they are an interesting
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genotyped. The classic single-marker biallelic TDT can
detect association due to linkage. Multimarker generaliza-
tions of the classic TDT enhance it by detecting marker
interactions, such as when a trait does not depend on a
single marker but there is association when considering
more than one marker together, which may point to linkage
disequilibrium (LD) or gene–gene interaction (epistasis).
This may be the case for genome-wide genotyping in
which a disease susceptibility locus cannot be genotyped
but some markers in LD with the locus can be. Thus, the
power of a multimarker TDT can signiﬁcantly enhance that
reached by a single TDT.
Different approaches have been used to deﬁne multi-
marker TDTs, each of them computing statistical signiﬁ-
cance in a different way. The most widely used are: (1)
TDTs that are straightforward extensions of the classic
single-marker biallelic TDT; (2) TDTs that group haplo-
types to reduce the degrees of freedom (df); and (3) TDTs
based on haplotype similarities to reduce df and improve
the test power.
The idea behind the ﬁrst of the approaches is simple. In
nuclear families with one affected child, there must be a
difference between the counts for non-transmitted and
transmitted haplotypes if they are directly associated with
the disease or in linkage with a susceptibility locus. The
most commonly used test in this approach is the classic
multimarker TDT (mTDT) (Spielman and Ewens 1996;
Lazzeroni and Lange 1998), a straightforward extension of
the biallelic monomarker TDT that can be used by con-
sidering each haplotype as a particular allele (Sham 1997;
Bourgain et al. 2001). Using this approach, we can also
consider introducing some non-linear transformation to the
transmitted/non-transmitted haplotype counts, such as
TDTE (Zhao et al. 2007), which is based on the concept of
entropy. More speciﬁc tests have also been deﬁned to
improve power for uncertain transmission cases (Clayton
1999; Zhao et al. 2000) or genotyping errors (Gordon et al.
2001). The main problem with tests using this approach is
that the df of the approximate v
2 distribution increase with
the number of haplotypes and thus permutation tests to
determine the null distribution may be required for sparse
data.
The second approach tries to reduce the df by grouping
haplotypesusingdifferentcriteriasuchashaplotypedistance
(Li et al. 2001) or a haplotype evolutionary relationship
(Seltman et al. 2001). These tests are very time-consuming
when used in genome-wide searches, as they have to ﬁrst
infer a model to group the haplotypes. As an example, a
cladogramforwhichitisassumed thatthereareno recurrent
disease mutations and no recombination or gene conversion
must be estimated. Violation of these strong assumptions
may decrease the general accuracy of the test.
The third approach also tries to reduce the df using
haplotype similarities. However, instead of counts for the
haplotype groups, similarity metrics are used, such as the
length measure used in the length contrast test (TDTLC) (Yu
et al. 2005) and the signed rank test (TDTSR) (Yu et al.
2005) and other metrics such as those used in the maximum
identity length contrast (MILC) test (Bourgain et al. 2001)
and the haplotype-sharing TDT (HS-TDT) (Zhang et al.
2003). For the TDTLC and TDTSR tests it is assumed that
there must be less variation among haplotypes transmitted
to affected offspring than among non-transmitted haplo-
types, as they distinguish the sign of the difference in the
measure between transmitted and non-transmitted data sets.
However, TDTs based on this assumption are more speciﬁc
than multimarker TDTs because they do not detect statis-
tically signiﬁcant differences in haplotype similarities
when these are greater among non-transmitted haplotypes.
This may occur when a haplotype is not in linkage with a
disease susceptibility gene but with a protective gene, so
that it will be more frequent in healthy individuals. There is
a more important issue in similarity-based TDTs: similarity
measures are computed by pairwise comparisons between
individuals. Thus, their computational complexity is a
quadratic function of the number of founders, in contrast to
most of TDT measures, which use sample counts and
increase linearly with the number of individuals. For cur-
rent genotype samples with up to a few thousand individ-
uals, similarity-based TDTs are thus a real burden.
Our goal was to deﬁne a computationally feasible
multimarker measure, named a proportional mTDT
(mTDTP), with high power and high robustness for popu-
lation admixture and stratiﬁcation with high locus speci-
ﬁcity as an association test. Therefore, association rates are
expected to quickly decrease with distance from a disease
susceptibility or protective locus. The measure belongs to
the ﬁrst of the approaches and is a generalization of mTDT
that weights partial results for each haplotype by its
probability frequency. The success of the measure in
improving locus speciﬁcity is based on two assumptions:
(1) according to the decrease in LD with chromosomal
distance, the frequency of haplotypes in linkage with a
disease haplotype is higher at shorter distances from the
disease locus; and (2) according to the ‘common disease,
common variant’ (CDCV) hypothesis, disease susceptibil-
ity variants are quite common in complex diseases and a
combination of several genes, rather than a single gene,
together with environmental factors, causes the disease. A
consequence of these assumptions is that haplotypes in
very strong LD with a disease or protective variant are
common and their frequency will notably decrease with
chromosomal distance.
Therefore, under both extremes of the expectrum of
chromosomal distances (the null hypothesis of no linkage
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123and no distance to the disease locus), there must be little
difference between mTDTP and mTDT; as we depart from
these, differences between the two tests arise: association
detected by mTDTP will decrease more rapidly as we
depart from the disease locus.
In ‘‘Methods’’, after analysis of mTDT and the reasons
why it cannot be considered a highly locus-speciﬁc test, we
propose mTDTP, a modiﬁcation of mTDT that considers
differences in haplotype frequencies to improve both
speciﬁcity and sensitivity. ‘‘Simulation studies’’ compares
different multimarker TDTs for different genetic models,
relative risks, haplotype lengths and total disease suscep-
tibility loci. As mentioned above, our goal was not only to
study test power and robustness under different conﬁgu-
rations, but also to observe the rate at which statistical
signiﬁcance decreases with chromosomal distance. Simu-
lations to study association rates at different chromosomal
distances from a disease susceptibility locus have been
performed for single-marker TDTs (Zhao et al. 2007). The
‘‘Simulation studies’’ compare sensitivity, speciﬁcity and
robustness for some state-of-the-art multimarker TDTs
deﬁned under different approaches. In ‘‘Real data sets’’, we
compare the power and locus speciﬁcity of our test
(mTDTP) with other TDTs using real trio samples for
Crohn and multiple sclerosis (MS) diseases and robustness
using control trio samples of individuals from the Inter-
national Hapmap Project (IHP) (HapMap-Consortium
2003), and ﬁnally ‘‘Discussion’’.
Methods
Assume that the data represent M nuclear families in which
one child is affected and that L SNPs are genotyped for all
the family members. As an example, for L = 2 and
assuming biallelic SNPs, there will be only k = 4 different
haplotypes: AB, Ab, aB and ab. Consider a sample com-
posed of all transmitted and non-transmitted haplotypes
when the parents are heterozygotic. Let n be the sample
size. Thus, subsamples ST and SU of transmitted and non-
transmitted haplotypes, respectively, both contain n/2
haplotypes.
Analysis of mTDT
mTDT (Spielman and Ewens 1996) was ﬁrst proposed as a
multiallelicextensionofthesimplebiallelicTDT.However,
byconsideringhaplotypesinsteadofalleles,thetestcanalso
be used as a multimarker TDT. The test is deﬁned as:
mTDT ¼
k   1
k
X k
i¼1
ðniT   niUÞ
2
niT þ niU
;
where k is the number of different alleles/haplotypes and
niT and niU are the number of times allele/haplotype i is
transmitted or not transmitted, respectively, considering
only heterozygous parental genotypes. The measure
asymptotically follows a v
2 distribution with k - 1 df
(v2
k 1) under no linkage if all heterozygous parental geno-
types have the same frequencies. A modiﬁcation of mTDT,
mTDTs, was deﬁned to guarantee it follows a v2
k 1 distri-
bution under the null hypothesis for every frequency for
heterozygous parental genotypes (Stuart 1955;S h a m
1997).
Both mTDT and mTDTs give all haplotypes the same
weight, regardless of their frequencies, as each summand is
the square of a standard normal distribution under the null
hypothesis. Even under the null hypothesis, the variability
in haplotype frequency is usually very high, with some
haplotypes very frequent and others very rare. Therefore,
the assumption that differences in transmission of multi-
marker haplotypes follow a v
2 distribution under the null
hypothesis of no linkage leads to a test that is too simplistic
and unrealistic. The larger the haplotypes, the greater is the
departure of the true null distribution from a v2
k 1 distri-
bution, as there are more differences among haplotype
frequencies.
We explore the consequences of this simpliﬁcation once
we introduce a generalization of mTDT that considers
differences in haplotype frequencies.
Deﬁnition of mTDTP
The test we propose here comprises a simple change in
mTDT, with weighting of the summand of each haplotype
by the haplotype frequency ni
n. Thus, mTDTP is deﬁned as:
mTDTP ¼
X k
i¼1
ni
n
ðniT   niUÞ
2
ni
¼
X k
i¼1
ðniT   niUÞ
2
n
;
where n is the overall number of haplotypes in parental
heterozygous genotypes (i.e., twice the number of hetero-
zygous parents).
Factors ni/n, Vi [ 1,…, k weight haplotypes according
to their frequencies, which means that differences in
transmission for the most frequent haplotypes have a
greater effect on the measure.
Taking into account that haplotype counts are corre-
lated, the asymptotic variance of mTDTP under the null
hypothesis is derived in Appendix 1.
It is already known (Sham 1997) that mTDT follows a
v2
k 1 distribution under the null in the case of equal parental
genotype frequencies. Therefore, it is straightforward to
show that mTDTP under the same situation of equal
parental genotype frequencies is equal to mTDT/(k - 1) so
that it follows a scaled v2
k 1:
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k 1:
Under different genotype frequencies, the variance
(Appendix 1) is larger than 2
k 1, so that, as it occurs with
mTDT (Sham 1997), TDTP will tend to be anticonservative.
A feature of this measure is that it reduces the impact of
random effects due to rare haplotypes without the need of
imposing a lower bound in haplotype counts for haplotypes
to be used, as is usually done by mTDT (Sham and Curtis
1995).
But the main feature of mTDTP is that, in contrast to
most multimarker TDTs which lack either in power or in
locus speciﬁcity, mTDTP has both: a high power and a high
locus speciﬁcity to detect disease susceptibility or disease
protective loci in complex diseases. The reason for the
measure to be comparable in power to the powerful mTDT
is that, assuming the CDCV hypothesis, the impact that
non-recombinant haplotypes have on the measure is high
when chromosomal distance to a disease locus is very
short, as their frequencies are high and so are their weights.
As we depart from the disease locus, the recombination
factor increases, non-recombinant haplotypes will be less
frequent in haplotypes transmitted to affected children and
their impact in the whole measure will decrease faster than
when weighting is not used, as in mTDT.
In order to characterize the distribution of mTDTP
under the null hypothesis of no linkage to avoid using
permutation tests to assess statistical signiﬁcance we
will ﬁrst consider the simpler but unrealistic situation of
haplotype counts being obtained from independent sam-
ples (‘‘Independent random variables: characterization and
approximation of a weighted v
2 distribution’’) as a start-
ing point to consider dependencies among them
(‘‘Dependent random variables: approximation of mTDTP
under the null hypothesis’’).
Independent random variables: characterization
and approximation of a weighted v
2 distribution
Under the null hypothesis of no linkage, Y2
i ¼
ðniT niUÞ
2
ni
follows a v2
1 distribution. If Y2
i were independent distribu-
tions, mTDTP, which is deﬁned as weighted summands,
would asymptotically follow a weighted v
2 distribution
Wk,w of k independent v2
1 distributions:
Wk;w ¼
X k
i¼1
wiv2
1;
with weights w ¼ð n1
n;...; nk
nÞ.
It is straightforward to show that Wk,w = (w1,…, wk)
can be considered a generalization of
v2
k
k (v2
k being a sum of
kv2
1 distributions) in which each v2
1 are weighted with the
only restriction
Pk
k¼1 wi ¼ 1. As mTDTP imposes the
weights to be w ¼ðn
n1;...n
nkÞ, in the case of equal parental
genotype frequencies and ignoring dependencies among
haplotypes (we will consider dependencies in the
‘‘Dependent random variables: approximation of mTDTP
under the null hypothesis’’), it would follow a
v2
k
k distribu-
tion under the null hypothesis of no linkage, a distribution
whose variance is 2k. Therefore, mTDTP for equal parental
genotype frequencies would have variance 2
k,a s
VarðXk
k Þ¼2k
k2 ¼ 2
k. In general, the variance of a weighted v2
1
distribution Wk,w = (w1,…, wk) is known to be (Johnson
et al. 1994):
VarðWkÞ¼2
X k
i¼1
w2
i :
The computation of the distribution function of
Ww = (w1,…, wk) is very complicated because of
numerical integration (Solomon and Stephens 1977;
Gabler and Wolff 1987). As we are interested in a TDT
for genome-wide association ﬁltering, permutation tests
should be avoided and an easily computable approximation
of the asymptotic test distribution under the null hypothesis
is required.
Several approximations (Solomon and Stephens 1977;
Gabler and Wolff 1987; Castao-Martı ´nez and Lo ´pez-
Bla ´zquez 2005) are available for a weighted sum of inde-
pendent v
2 distributions Wk,w = (w1,…, wk). The one used
here is based on two limiting distributions that are identical
to W in the ﬁrst three moments, with only minor differ-
ences in higher moments (Gabler and Wolff 1987). Given a
statistic s, PrðW  sÞ is computed by choosing the shortest
value from the two limiting distributions:
pðW  sÞ¼min
GðsÞ¼
P
wic 1
2wi; s
2wi
  
UðsÞ¼c k
2; s
2d
  
¼ Prðv2
k  s=dÞ;
(
ð1Þ
where c(a, b) is the normalized lower incomplete gamma
function (Abramowitz and Stegun 1972), also called the
incomplete gamma function, and d ¼
Q
wi
1=k.
It is straightforward to show that in the case of equal
weights (wi ¼ 1
k;8if1;...;kg), d ¼ 1
k and the approximation
turns out to be a true weighted v
2 distribution, as the three
distribution functions are exactly the same.
Dependent random variables: approximation of mTDTP
under the null hypothesis
As each individual carries a pair of haplotypes, haplotype
counts are not obtained from independent samples.
Therefore, Y2
i ;i 2f 1;...;kg are not independent v2
1 vari-
ables and thus mTDTP under the null is not Wk;w¼ð
n1
n ;...;
nk
n Þ.
Therefore, the exact distribution needs to be assessed.
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123As it was said above, under the null hypothesis of no
linkage and when the frequencies of all parental hetero-
zygous genotypes are equal, mTDT asymptotically follows
a v2
k 1 distribution and, therefore, mTDTP = (k - 1)mTDT
a scaled v2
k 1. For k = 2, the asymptotic variance is 2.
Moreover, for k = 2, mTDTP also reduces to the simple
(i.e., monomarker, monoallelic) TDT.
To use the approximation of the weighted sum of v
2
distributions W considered above (Gabler and Wolff 1987)
in order to obtain the distribution of mTDTP under the null
hypothesis and considering that the v
2 distributions are not
independent, we have modiﬁed the limiting distributions G
and U so that it can be easily shown they will be exactly a
scaled v2
k 1 with scale factor k - 1 under equal genotype
heterozygous frequencies.
Therefore, the approximation will be:
PrðW  mTDTPÞ¼min
P
wicð 1
2wi
ðk 1Þ
k ; mTDTP
2wi
ðk 1Þ
k Þ
Prðv2
k 1  mTDTP
ðk 1Þ
k =dÞ;
(
ð2Þ
where wi ¼ ni
n and d ¼
Qk
i¼1 wi
1=k
. A pseudo code
describing how to compute p values is given at Table 1 and
a computer program to compute it is provided at the sup-
plementary website.
In order to check whether mTDTP follows a weighted v
2
distribution in the more general case of different parental het-
erozygous genotype frequencies, we performed permutations
in ‘‘Simulation studies’’ (Zhang et al. 2003;Y ue ta l .2005)
and we did not ﬁnd signiﬁcant differences (data not shown).
Simulation studies
We compared the performance of our solution mTDTP with
several state-of-the-art multimarker TDTs, such as the
classic mTDT and other TDTs based on different approa-
ches: the similarity-based tests mTDTLC and mTDTSR, the
entropy-based mTDTE and the group-based mTDTT1.
mTDT1T (Ott 1999)i sav2
1 test under the null hypothesis of
no linkage that checks differences between the haplotype
with more signiﬁcant differences niT - niU and the rest of
the haplotypes in a sample.
We also modiﬁed mTDT using some well-known cor-
rections of v
2 tests to improve the speciﬁcity by reducing
random errors due to low frequencies and some modiﬁca-
tions of these (Appendix 2), such as the Yates (1934)
correction mTDTY, its modiﬁcation mTDTYP and the
Laplace corrections mTDTL1 and mTDTL2.
Besides robustness to population stratiﬁcation and
power, we are interested in measuring locus speciﬁcity.
Thus, the decrease in the rate of associations detected with
incremental linkage distance or recombination rates (h)
was assessed considering the extreme points from h = 0
for which all associations detected are true positive asso-
ciations (power) and from h = 0.0002 for which most
associations detected are type I errors.
Statistical signiﬁcance levels were obtained using a
permutation procedure for mTDTLC, mTDTSR and mTDTE
(Zhang et al. 2003; Yu et al. 2005). For mTDTP, the
approximation of a weighted v
2 with weights being the
haplotype frequencies was used (‘‘Independent random
variables: characterization and approximation of a weigh-
ted v
2 distribution’’). For the remaining tests, the exact v
2
distribution was used.
Simulation set-up
We tried to reproduce the same simulations used in several
studies to check TDT accuracy (Zhang et al. 2003;Y u
et al. 2005) and explained in the following subsections.
As our main goal is to have a useful test to perform
genome-wide association ﬁltering, computational com-
plexity is a main issue and a linear relationship between
computational complexity and the number of SNPs is
highly desirable. Therefore, we applied the tests in a very
feasible way in which only consecutive or overlapping
clusters of SNPs (known as sliding windows) were tested
together. For simulations of a cluster as suggested by
Crawford et al. (2004), we assumed that recombination
rates among all the markers tested is very low, which is
equivalent to assuming that they belong to the same low-
recombination block (Daly et al. 2001). The recombination
fraction within blocks (hB) for a common population with
exponential growth, such as an African population, has
Table 1 Pseudo code describing how to compute p values for mTDTP
using the approximation given in Eq. 2 (Gabler and Wolff 1987)
Inputs:
k: the number of different haplotypes in the sample
weights: a list of k weights
HP: the value of statistics mTDTP for the current sample
Output:
result: p value
Description:
result = 0
DS = 1
R1 = 0
df = k - 1
Foreach haplotype i = 1,…,k
dZero = 0.5/weights(i)
R1 = R1 ? weights(i)*gammai(dZero, HP*dZero)
DS = DS*weights(i)
R2 = pValTestChiSquare(HP/DS
1/k, k)
result = max(R1, 1 - R2)
gammai(a, b) is the normalized lower incomplete gamma function,
pValTestChiSquare(a, b) computes the p value for a using v2
b, i.e.,
pðv2
k  aÞ, and max(a, b) returns the maximum of a and b
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123been estimated as 0.000088 (Hinds et al. 2005) and we
used this value in the simulations.
We also modiﬁed the method for introducing a disease
mutation compared to other studies (Sham 1997; Zhang
et al. 2003; Yu et al. 2005). Instead of considering only
one ancestral chromosome with the disease-causing muta-
tion, or the improvement of using two ancestral chromo-
somes (Zhang et al. 2003), a more realistic simulation of
inheritance of complex diseases was used, in which the
number of ancestral disease chromosomes can change
according to the coalescent model, as any other gene does.
Populations were drawn using msHOT (Hellenthal and
Stephens 2007), a program for generating samples based on
the coalescent model that incorporates recombination. The
samples for all the populations were obtained using trio-
Sampling, a computer program available on the supple-
mentary website. In the following subsections, we describe
the simulations in detail and highlight any departures from
the set-up commonly used (Sham 1997; Zhang et al. 2003;
Yu et al. 2005). A more detailed explanation of the simu-
lations performed can be accessed on the supplementary
website.
Robustness
To check the robustness to population stratiﬁcation, sim-
ulations were performed as described by Zhang et al.
(2003) and Yu et al. (2005). Therefore, we considered
stratiﬁed populations. However, instead of using samples
of 200 nuclear families (Zhang et al. 2003; Yu et al. 2005),
we produced samples with 500 nuclear families. Moreover,
we used recombination fraction from the markers to the
disease locus h = 0.5 to represent a true null. Association
rates were estimated based on 1, 000 replications. Families
were randomly sampled by choosing haplotypes with the
disease mutation and randomly choosing the haplotypes
transmitted to children considering recombinations. For the
ﬁrst subpopulation, the minor allele frequency (MAF) for
the markers was 0.5 and the probability of the disease
mutation in parents pD was 0.2. For the second subpopu-
lation, different MAFs q for the markers were used:
q [ {0.1, 0.3, 0.5} and pD was 0.3. Different proportions of
individuals from the ﬁrst sample were used,
pp 2f 1=2;1=4;1=6g. Therefore, by varying pp and q, nine
different scenarios where considered to test the robustness.
Locus speciﬁcity and sensitivity
Simulations for power (sensitivity), i.e., assuming no
recombination between the disease susceptibility locus and
the markers tested, were similar to those used in several
studies assuming one founder disease haplotype (Lam et al.
2000; Zhang et al. 2003; Yu et al. 2005), except that SNPs
used were assumed to be in high LD, i.e., they belong to the
same low-recombination block (Daly et al. 2001). There-
fore, we performed simulation analyses using haplotype
data sets for 200 nuclear families (family trios with both
parents and an affected child). Association rates were
estimated based on 100 replications of the simulations
described below (Sham 1997; Zhang et al. 2003; Yu et al.
2005).
Four parameters were taken into account to generate
samples from populations (one for each population).
Table 2 shows the parameters and their values. The ﬁrst
parameter, the relative risk of being homozygous for the
risk allele, RR, was varied from 2 to 10 in steps of 2 in the
simulations. The second parameter is the number of disease
loci used: one and two different disease susceptibility loci
were considered. The third parameter is the genetic disease
model. Affected and non-affected individuals were drawn
by considering different genetic models for one and two
disease susceptibility loci (Yu et al. 2005). Additive,
dominant and recessive models were considered for only
one locus. Additive, domAndDom, domOrDom, recOrRec,
threshold and modiﬁed models were considered for two
loci. Different relative genotype risks (RR) of having
genotype DD, deﬁned as Prðdisease j DDÞ=Prðdisease j
ddÞ (one disease locus) and of having joint genotypes DD
and EE, deﬁned as Prðdisease j DD;EEÞ=Prðdisease j
dd;eeÞ (two disease loci), where d and e are the normal
alleles and D and E the disease alleles, were used. Relative
risks for all other genotypes were computed based on RR
(Fan and Xiong 2001; Yu et al. 2005) (see Table S1 on the
supplementary website).
The fourth parameter checks the decrease in association
rate due to chromosomal distance. We considered ﬁve
different recombination fractions (h) from the markers to
the disease susceptibility locus, ranging from perfect LD
(no recombination) to h = 0.0002. Use of the recombina-
tion fraction to choose markers for the samples forced us to
modify the pattern of population growth to simulate the LD
decrease with distance in a more realistic way in a human
population (Kruglyak 1999; Crawford et al. 2004). For
greater consistency with real populations and complex
diseases in which different numbers of founders can carry
the disease loci, we used the coalescent model (Nordborg
2001) to draw populations with a variable number of
founder haplotypes and population growth as explained
Table 2 Values used to conﬁgure sample parameters used in speci-
ﬁcity/sensitivity simulations
Relative risk 2, 4, 6, 8, 10
Genetic model Additive, recessive, dominant
h to disease loci 0, 5e-05, 1e-04, 1.5e-04, 2e-04
Haplotype length 1, 2, 4, 6, 8, 10
330 Hum Genet (2010) 128:325–344
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Disease founder haplotypes were chosen by selecting one
SNP with a mutant allele with frequency in the interval
[0.2, 0.4] to mimic a common disease (Yu et al. 2005).
We later produced a second set of simulations with more
realistic relative risks (1.2, 1.6, 2.0, 2.4 and 2.6) and
samples of 500 nuclear families and focused only in the
most powerful statistics which were also highly efﬁcient
(computational complexity linear to the number of
families).
In order to know how frequencies of the disease muta-
tion affect mTDTP and the other measures, we generated a
third set of simulations with same parameters as the second
one but considering the frequency of the disease mutation
in the interval [0.1, 0.2].
Simulation results
The sensitivity and speciﬁcity of the tests were analyzed by
counting rates of association for different chromosomal
distances from markers to disease loci.
Table 3 shows type I error results for mTDTP in the
presence of population stratiﬁcation and admixture for
nominal levels of a = 0.01 and a = 0.05. Values shown
are rates of samples in which association was found to be
statistically signiﬁcant, for all conﬁgurations of pp and q
values used. As TDTP is a scaled v
2 distribution only under
equal parental genotype frequencies and its variance is
larger without this constraint, the measure tends to be an-
ticonservative, so that p values may upward deviates from
the nominal value. However, mTDTP is mainly proposed to
perform genome-wide search to be more locus speciﬁc than
the current alternatives. Moreover, association p values
will be averaged in a sliding window approach and only
associations found at few consecutive windows (consider-
ing enough marker density) will be considered to perform a
further ﬁne mapping.
Results for sensitivity (h = 0) show that mTDT, mTDT1T
andmTDTPachievethebestresultsunderallscenariostested,
withlittledifferencesamongthethreeofthem,whereaslocus
speciﬁcity results (h [ {0.00005, 0.0001, 0.00015, 0.0002})
show that mTDTP has better performance than all the other
methods. Therefore, association rates decrease faster with
mTDTPthanwiththeothermethodswheneverrecombination
fractionhtothediseaselocusincreases.Thesedifferencesare
moreappreciablewhenweincreaseRRandhaplotypelength.
Therefore, Fig. 1 shows results (a = 0.05) for haplo-
types of length 4 and RR = 6 for one (ﬁrst column) and
two disease loci (second and third columns) under different
disease models. For clarity, in this plot mTDTP was only
compared with the two other TDTs that showed the highest
power in all our simulations, mTDT and mTDT1T. Figures 2
and 3 show results for the same conﬁgurations used in
Fig. 1 except that haplotype length is 10 and RR is 4 and 8,
respectively. In general, differences between the tests
increase with haplotype length and relative risk, with
greater differences for haplotypes of length 10 and RR = 8
(Fig. 3) than for smaller haplotype length and/or RR
(Fig. 1).
Results for a = 0.05 and haplotype lengths of 1, 2, 4, 6,
8 and 10 for one locus are available on the supplementary
web site (Figures S1–S6). Results for two loci and disease
models Additive, DomOrDom and RecOrRec (Figures S7–
S12) and for two loci and disease models DomAndDom,
Threshold and Modiﬁed) Figures S13–S18) are available
on the supplementary web site. We also used the correc-
tions to the small data problem mentioned in Appendix 2
(Figs. S19–S36). As expected, the same pattern was always
observed: all the corrections improved the speciﬁcity at a
cost of a reduction in sensitivity. The higher the correction,
the stronger was this pattern. It should be noted that for
haplotypes of length 1, i.e., only one marker, mTDT,
mTDT1T and mTDTP are equivalent and therefore yield the
same results. Differences among them increase with hap-
lotype length.
As mTDT and mTDTP showed a constant pattern of
higher power than the other statistics for all the scenarios
provided, we focused in them together with mTDTY, the
measure that performs the lightest correction to the small
Table 3 Type I error rates in presence of population stratiﬁcation and
admixture and recombination factor the the disease locus 0.5 based on
1,000 simulations
a MAF pp
0.01 0.1 0.5 0.009
0.01 0.3 0.5 0.012
0.01 0.5 0.5 0.013
0.01 0.1 0.75 0.012
0.01 0.3 0.75 0.016
0.01 0.5 0.75 0.015
0.01 0.1 0.833 0.011
0.01 0.3 0.833 0.013
0.01 0.5 0.833 0.013
0.05 0.1 0.5 0.054
0.05 0.3 0.5 0.063
0.05 0.5 0.5 0.071
0.05 0.1 0.75 0.060
0.05 0.3 0.75 0.061
0.05 0.5 0.75 0.052
0.05 0.1 0.833 0.055
0.05 0.3 0.833 0.056
0.05 0.5 0.833 0.058
Results for different MAF in the second subpopulation (q) and dif-
ferent proportion of trios from the ﬁrst subpopulation (pp), obtained
by TDTP for nominal levels a = 0.01 and a = 0.05
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123data problem. Disregarding mTDTLC and mTDTSR made
feasible to perform a second and third set of simulations
using a larger number of nuclear families: 500. We did not
use mTDT1T because it chooses the haplotype with the
highest power and therefore it requires multitesting cor-
rection. When we used Bonferroni correction (data not
shown) the measure was not competitive any more, in
agreement with the already referred over-correct associa-
tion results (Tang et al. 2009).
Using the second set of simulations, Figs. 4, 5 and 6
show association rates of mTDT, mTDTP and mTDTY (blue,
red and green, respectively) for nominal level a = 0.05 and
relative risks of 2, 1.6 and 2.4 and haplotypes of lengths 4,
10 and 10, respectively. By increasing the number of
samples, the power increases and associations can be
detected even with lower and more realistic relative risks.
Differences among the three tests can still be observed for
all the scenarios used.
Results for a = 0.05 and haplotype lengths of 1, 2, 4, 6,
8 and 10 for one locus are available on the supplementary
web site (Figs. S37–S42). Results for two loci and disease
models Additive, DomOrDom and RecOrRec (Figs. S43–
S48) and for two loci and disease models DomAndDom,
Threshold and Modiﬁed (Figs. S49–S54) are available on
the supplementary web site.
The third set of simulations was produced in order to
analyze how the frequency of the disease mutation affects
power in the three measures. Figure 7 shows association
Fig. 1 Association rate based on 100 simulations of 200 family trios
as a function of the recombination rate using haplotypes of length 4
and different genotype models (rows). The ﬁrst column shows results
for one disease susceptibility locus and the second and third show
results for two disease loci. A nominal level of a = 0.05 and a
relative risk of 6 were used for all plots. Results for mTDTP, mTDT
and mTDTY are plotted in red, blue and green, respectively
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123rates(100simulationsof500familytrioseachwereused)for
haplotypes of length 10 and different relative risks (x-axis).
Simplelinesshowresultsfordiseasemutationfrequenciesin
theinterval[0.2, 0.4]whilelineswithdiamondsshowresults
fordiseasemutationfrequenciesintheinterval[0.1, 0.2].On
lightoftheseplots,twomainresultsderive:forequalrelative
risk(1)powerislowerwithlargerfrequenciesand(2)mTDT
approaches mTDTP with low frequencies and even outper-
forms it. A possible reason for the ﬁrst result, i.e., a higher
power with lower mutation frequencies and equal relative
risks, is that lower frequencies usually mean more recent
mutations and there are less chances of recombinations
between the disease variant and the neighboring haplotype
so that larger differences would exist between transmitted
and non-transmitted counts. It has to be noted that we used
one and two disease loci simulations. The more loci were
involved, the higher the chances of having a sample with no
individuals with the disease variant at one locus, as relative
risk can be still high because of the presence of a disease
variant at a different locus and therefore power would
decrease. The second result can be explained by considering
again that lower disease variant frequencies usually mean
more recent mutations. Hence, most of the neighboring
SNPs already mutated and many different haplotypes arose
so that there are less chances for the disease mutation to
occur at a chromosome with a very common haplotype.
Thus, a non-recombinant haplotype with a disease variant
will have a lower frequency. Therefore, weighting trans-
missiondisequilibriumbyhaplotypefrequencieswillreduce
power compared with the lineal mTDT.
Fig. 2 Association rate based on 100 simulations of 200 family trios
as a function of the recombination rate using haplotypes of length 10
and different genotype models (rows). The ﬁrst column shows results
for one disease susceptibility locus and the second and third show
results for two disease loci. A nominal level of a = 0.05 and a
relative risk of 4 were used for all plots. Results for mTDTP, mTDT
and mTDTY are plotted in red, blue and green, respectively
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123Real data sets
As in the simulation study, besides mTDT and tests
designed to cope with the problem of small data (mTDTY,
mTDTYP, mTDTL1 and mTDTL2), we used the same tests for
state-of-the-art data sets for comparison with mTDTP:
mTDT1T, mTDTE, mTDTLC and mTDTSR. We added a
further test for the real data sets. mTDT1U is the same as
mTDT1T but uses the most frequent non-transmitted instead
of the most frequent transmitted haplotype. Our purpose
was to consider whenever a disease is more common in the
absence of a protective disease locus in affected individu-
als, a situation for which mTDT1T would be powerless.
A multimarker TDT for genome-wide association sear-
ches requires a very efﬁcient exploration approach for the
method to be feasible. A possible approach would consist
of dividing the SNP sequence into blocks of low recom-
bination using an algorithm based on conﬁdence intervals
(Gabriel et al. 2002). However, we chose to split regions in
a block-free way because a low-recombination block has
sensible differences depending on the deﬁnition used by
the algorithm to split a region in blocks (Halldo ´rsson et al.
2004). Thus, we used sliding windows (Daly et al. 2001)t o
apply the test to very small subsets of consecutive markers,
such as 6, 8 or 10 markers. Each subset is a window and
windows can share markers.
We used sliding windows of 1, 2, 4, 6, 8 and 10 SNPs
per window and an offset of 1 to compute p values. Sig-
niﬁcance levels were computed for each sliding window
using standard permutation tests (1,000 permutations) for
Fig. 3 Association rate based on 100 simulations of 200 family trios
as a function of the recombination rate using haplotypes of length 10
and different genotype models (rows). The ﬁrst column shows results
for one disease susceptibility locus and the second and third show
results for two disease loci. A nominal level of a = 0.05 and a
relative risk of 8 were used for all plots. Results for mTDTP, mTDT
and mTDTY are plotted in red, blue and green, respectively
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123when the null distribution is unknown. For all tests for
which the null distribution or its approximation is known,
we used that distribution to compute p values.
Phase reconstruction
We inferred haplotype frequencies using all the information
from the family (Yu et al. 2005; Rinaldo et al. 2005). Those
haplotypes that were unsolved using family information,
were inferred using the E-M algorithm under the restriction
offamilyinformation(Abecasiset al. 2001;Yuet al.2005).
To avoid inaccurate haplotype reconstruction, E-M
algorithm is usually applied within a low recombination
block (Niu et al. 2002). However, despite we ﬁrst per-
formed a preliminary division of the chromosome in blocks
of low recombination by using some of the several algo-
rithms proposed to do that (Gabriel et al. 2002), we ﬁnally
decided to use sliding windows because of the following
two reasons.
On one hand, results from different block building
algorithms are very distinct (Halldo ´rsson et al. 2004) and
they may bias results from TDT measures. Moreover, the
chances of an haplotype of few SNPs to cover more than
one block are being reduced with the increase in the
number of sequenced SNPs. As an example, with a current
genome-wide SNP array of about 500,000 SNP markers,
and considering the estimation of 20,700 bp as the average
block size in Caucasian populations (Hinds et al. 2005)i t
means about 20 SNPs per block. For windows of length 10,
there are few chances for the haplotype to span through
more than one block.
On the other hand, in trio samples the E-M algorithm is
used under the restriction of family information (Zhang
et al. 2003; Yu et al. 2005) and, therefore, it is more
accurate than the simple E-M to infer the phase, even
beyond block boundaries, as the only positions whose
transmission/non-transmission alleles cannot be solved
using family information are those for which the three
Fig. 4 Association rate based on 100 simulations of 500 family trios
as a function of the recombination rate using haplotypes of length 4
and different genotype models (rows). The ﬁrst column shows results
for one disease susceptibility locus and the second and third show
results for two disease loci. A nominal level of a = 0.05 and a
relative risk of 2 were used for all plots. Results for mTDTP, mTDT
and mTDTY are plotted in red, blue and green, respectively
Hum Genet (2010) 128:325–344 335
123family members are heterozygotic (Sebastiani et al. 2004).
We compared (data not shown) results of two main ways to
proceed within each family: (1) to choose the most likely
phase according with the E-M algorithm under the
restriction of family information or (2) to use weighted
phases using as weights the frequencies reported by the
algorithm (Zhang et al. 2003; Yu et al. 2005) and, in
agreement with these works, found no signiﬁcant differ-
ences among the two methods. Therefore, we opted for
using the ﬁrst one of the two choices, for being the one
with lower computational complexity.
Data sets used
We used nine data sets of trio genotypes, one with indi-
viduals with Crohn’s disease (affected-Crohn) and the
others with individuals with MS. The Crohn data set is a
publicly available set originally used by Rioux et al.
(2001).
Table 4 provides information about the MS data sets.
Eight regions corresponding to risk loci for MS previously
determined in well-powered studies were chosen. Geno-
type information for these regions was obtained from a
genome-wide association study performed for the Interna-
tional Multiple Sclerosis Genetic Consortium. A DNA
microarray (GeneChip Human Mapping 500K Array Set,
Affymetrix) was used to examine 334,923 common genetic
variants in 931 family trios consisting of a patient with MS
and both parents (International Multiple Sclerosis Genetics
Consortium et al. 2007).
For all the sets used, we prepared data sets for unaf-
fected individuals from data publicly available at the
website of the IHMP (HapMap-Consortium 2003) con-
sisting of genotype data for 30 family trios (HapMap Phase
II) typed in the CEPH population, who are Utah residents
with ancestry from Northern and Western Europe. The tests
for unaffected trios are used as a control, since an associ-
ation found in unaffected individuals may point out to a
Fig. 5 Association rate based on 100 simulations of 500 family trios
as a function of the recombination rate using haplotypes of length 10
and different genotype models (rows). The ﬁrst column shows results
for one disease susceptibility locus and the second and third show
results for two disease loci. A nominal level of a = 0.05 and a
relative risk of 1.6 were used for all plots. Results for mTDTP, mTDT
and mTDTY are plotted in red, blue and green, respectively
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123disease protective locus, genotypic errors or changes in
Hardy–Weinberg equilibrium.
Crohn affected and unaffected data sets from the IHMP
are all available on the supplementary website.
Results for real data sets
In general, mTDTP seems to be more locus-speciﬁc than the
other tests used, with competitive power (see Fig. 8 for loci
KIAA0350 and IRF5 for a window width of 10 and Figs.
S38–S43 on the supplementary website for all loci and
window widths 1, 2, 4, 6, 8 and 10).
To show these results we used comparative TDT
(CTDT) maps, which are drawn by averaging the p values
for each sliding window covering the same marker. A
computer program to construct these maps was built using
BioCASE (Montes and Abad-Grau 2009). Each row in a
CTDT map represents sample results obtained from a dif-
ferent TDT. The height of the colored bar for each marker
represents the range of the p value. If the p value is greater
than 0.05, there is no color for that marker position,
meaning that association is not signiﬁcant. If the p value is
less than 0.01, the colored bar has maximum height.
The association of the KIAA0350/ CLEC16A locus
with MS was reported by the IMSGC genome-wide
association study (International Multiple Sclerosis Genet-
ics Consortium et al. 2007), however it did not reached
genome-wide signiﬁcance. Later on, it was replicated in
several populations and now is considered a risk factor for
MS (Martı ´nez et al. 2010; M et al. 2009). Our results for
the KIAA0350 locus (Fig. 8a) reveal that mTDTP detected
a strong association (maximum height bar) from locus
rs28087 to locus rs248836. Compared with mTDT and
the alternative corrections for coping with the small
data problem, mTDTP is more speciﬁc, as the range of
markers with maximum association is smaller. The other
tests were not able to detect association, with p values less
than 0.01.
Fig. 6 Association rate based on 100 simulations of 500 family trios
as a function of the recombination rate using haplotypes of length 10
and different genotype models (rows). The ﬁrst column shows results
for one disease susceptibility locus and the second and third show
results for two disease loci. A nominal level of a = 0.05 and a
relative risk of 2.4 were used for all plots. Results for mTDTP, mTDT
and mTDTY are plotted in red, blue and green, respectively
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123Interferon regulatory factor 5 (IRF5) has been found
to be associated with MS in a cadidate gene study in
several population (Kristjansdottir et al. 2008). Results for
IRF5 (Fig. 8b) show an interesting pattern in mTDTP and
mTDT1T: there is a locus with maximum association
(rs3807306), which may mean that the actual disease
susceptibility locus is somewhere between this marker and
its left and right neighbors, and a continuous decrease with
distance from the marker at maximum association either to
the left or to the right along the chromosome. This pattern
only applies to the right side of the locus, with maximum
association for other mTDT measures. Thus, mTDTP again
yields the maximum information: the power is maximum
for a shorter region and signiﬁcantly decreases with dis-
tance from this region.
However,results obtained bymTDTPdo notalways show
a narrower region of association. Sometimes the region is as
wide or even wider than that detected by mTDT. This is the
case for the human leukocyte antigen (HLA) locus (see the
Fig. 7 Association rate based on 100 simulations of 500 family trios
as a function of the recombination rate using haplotypes of length 10
and different genotype models (rows). The ﬁrst column shows results
for one disease susceptibility locus and the second and third show
results for two disease loci. A nominal level of a = 0.05 and a
haplotype length of 10 were used for all plots. Results for mTDTP,
mTDT and mTDTY are plotted in red, blue and green, respectively.
Simple lines show values for frequency of the disease mutation in the
interval [0.2, 0.4] while lines with diamonds show results for
mutation frequencies in the interval [0.1, 0.2]
Table 4 Real data sets
Data set ch. First SNP Last SNP SNPs
EVI5 1 92388330 93651891 93
IL2R 10 6103680 7715013 353
IL7R 5 35847586 35991293 35
HLA 6 30736061 33163225 468
KIAA0350 16 11050221 11226546 26
CD226 18 65550188 65997985 38
CD58 1 116677600 116983610 19
IRF5 7 128055671 128309250 15
The ﬁrst and last SNPs columns show the physical SNP position
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123ﬁfth CTDT map in Figs. S38–S43 on the supplementary
website). This would mean that there is no single gene
associated with the disease at that locus and other associa-
tions were detected as a result of linkage, but many of them
along the HLA locus can inﬂuence disease onset. This is
consistentwithotherstudiessuggestingthattheHLAclassII
genes (HLA-DRB1) are the major determinants of MS risk
in the major histocompatibility complex (MHC) region.
Despite the recognized effect of HLA class II genes on risk,
it is not clear what contributions other genes in this region
may make. The MHC region has extensive LD spanning
several megabases (Mb) and high levels of variability, with
the HLA genes having hundreds of alleles. The MS data set
analyzed here has not been genotyped at a sufﬁciently
marker density across the entire MHC region to model the
class II effects appropriately to be conﬁdent that the asso-
ciations are not attributable to either the class II loci them-
selves or other (untyped) loci within the region.
Discussion
With current SNP genotype samples for family trios of a
few hundred or thousand trios, the locus speciﬁcity of a test
Fig. 8 Comparative TDT maps
for loci, a KIAA0350 and b
IRF5 data sets using sliding
windows of width 6 and offset
1. Rows in gray below each
TDT map (colored on a white
background) show results for
the IHMP data sets as a control
test. Results correspond to the
following TDTs from top to
bottom: mTDTP (red), mTDT
(blue), mTDTY (green), mTDTYP
(cyan), mTDTL1 (purple),
mTDTL2 (scarlet), mTDTE
(violet), mTDT1T (orange),
mTDT1U (pink), mTDTLC
(black) and mTDTSR (brown)
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123has become as important as its power, as it is very common
to ﬁnd associations due to linkage in loci at a considerable
distance from the disease susceptibility locus. These
associations usually cannot be replicated in other samples
from close populations, as they are at some distance from
the disease susceptibility locus and their haplotypes may
have departed from the common ancestors in the ﬁrst
sample used due to recombination. A lack in locus speci-
ﬁcity means they may detect association at considerably
large chromosomal distance to the disease susceptibility
locus. These associations can be considered spurious
associations, as they do not point out to a susceptibility
locus or positions very close to it and they will be hardly
replicated in a lightly different sample. Thus, more than
two markers may be used so that power will increase with a
lower risk of low speciﬁcity. Therefore, it is very important
to consider the locus speciﬁcity of TDTs to increase the
chances of ﬁnding truly risky haplotypes, i.e., those actu-
ally at the disease susceptibility locus or at a very short
distance from it, and thus the chances of replicating the
results in other samples. With this goal, we proposed
mTDTP, which is based on mTDT, one of the ﬁrst multi-
marker TDTs. mTDT, together with mTDT1T and mTDTP
has the highest power under a wide range of scenarios in
light of our simulations. Because mTDTP is based on
mTDT, the new assumption used to deﬁne mTDTP is crucial
to improve locus speciﬁcity without risking the high power
of mTDT. Therefore, the new assumption and thus the
modiﬁcation introduced by the test had to be as simple as
possible for the test to be as generic as mTDT and to focus
on reducing association rates with chromosomal distance to
the disease susceptibility locus at a faster rate. To achieve
this, the new assumption was very speciﬁc: association
decreases with chromosomal distance from a speciﬁc locus
because of recombinations. As a consequence, haplotypes
in phase with a disease variant at the time at which a
variant appeared would recombine more often with other
haplotypes with increasing distance from the disease locus.
Thus, in a sample of trios with affected offspring, the
frequency of these non-recombinant haplotypes will be
lower than if the haplotype were closer to the disease locus.
Therefore, by weighting each summand in mTDT by the
haplotype frequency, we reduce the effect that haplotypes
at some chromosomal distance to a disease locus can have
on the measure because of linkage. Moreover, in positions
close to the disease locus, and assuming the CDCV
hypothesis, there would be very few, but common, haplo-
types with strong association with the risk variant, so that
the weighting procedure will not reduce the power.
We performed simulations under a wide range of pop-
ulation and disease variables, such as the number of disease
loci, the disease model, the relative risk of a genotype,
haplotype length, etc. Simulations conﬁrmed the
correctness of the assumptions and the improvement in
locus speciﬁcity achieved by mTDTP without reducing the
power. We also used several real trio data sets with
affected offspring.
As these TDTs are to be applied to genome-wide data
sets. a multiple testing correction should be performed.
Multiple testing correction for GWAS is currently a very
active research topic (Betensky and Rabinowitz 2000; Wei
et al. 2009; Gorlov et al. 2009), as most of the current
approaches do not consider LD between different markers
and they usually over-correct association results and
therefore true-effect associations may be missed. As the
objective in the simulations performed was to compare
power and locus speciﬁcity from different tests, we did not
perform multiple testing corrections in any of the tests and
p values were directly compared. Moreover, mTDT1T and
mTDT1U, which choose the haplotype with the lowest
p value, were not competitive when the Bonferroni cor-
rection was applied. Current real genome-wide data usually
have hundred thousand markers. We considered using
sliding windows and comparative TDT maps as visual tools
for genome-wide screening, including also the use of
IHMP samples as controls. In these two visual tools,
instead of a unique p-value for each window with multiple
testing correction, average p-values for all the windows a
marker belongs to are drawn in order to reduce the chances
of spurious associations. Therefore, we chose a simple
approach to detect association decay with distance in order
to select a region to perform a further ﬁne-mapping study
including a more dense screening over the selected region
and sample replication for which multiple testing correc-
tion may be required.
The results obtained using mTDTP analysis for the MS
data set showed more precise deﬁnition of MS implicated
variants among the loci analyzed. KIAA0350/CLEC16A
has been associated with several autoimmune diseases in
genome-wide association and replication studies (Interna-
tional Multiple Sclerosis Genetics Consortium et al. 2007;
Todd et al. 2007;M a ´rquez et al. 2009). Fine mapping of
the region for type 1 diabetes (T1D) by resequencing of
exons and ﬂanking regions and SNP genotyping for the
surrounding genes revealed that the most probable causal
variant would be localized at the 30 end of the KIAA0350/
CLEC16A gene. Results for the mTDTP CTDT map of
the KIAA0350/CLEC16A locus using MS data reveal
that the region with greatest association is the last 30 60
Kbp of the gene, whereas the other TDTs extend the
association to the intergenic 30 region. These mTDTP
results pointed to the 30 end of the KIAA350 gene as the
causative association region in MS as described for T1D.
We also observed for some other loci that the mTDTP map
extends to a larger region than the other TDT maps. This is
the case for the IRF5 locus. The most probable causal
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123variant for association of the IRF5 locus with MS is a
functional 5-bp biallelic insertion–deletion polymorphism
that differentially binds the SP1 transcription factor to the
IRF5 promoter (Kristjansdottir et al. 2008). The mTDTP
map revealed maximal association at IRF5 and extended it
to the 50 region, including the IRF5 promoter, whereas the
other maps did not reveal any association with the IRF5
promoter. In designing a ﬁne mapping of the IRF5 locus
based on mTDT, mTDTY, mTDTYP, mTDTL1 or mTDTL2
results, we would be erroneously focusing on the middle of
the gene instead of on the promoter, where the most
probable causative variants are located.
An interesting question arises about whether mTDTP
would be still useful when disease-susceptibility variants
have very low frequencies, i.e., under the ‘common dis-
ease, many rare variants’ (CDMRV) hypothesis. In general,
GWAS are not suitable to capture rare variants and other
techniques, such as DNA resequencing of candidate genes
are often used (Bodner and Bonilla 2008). However, it is
being recently claimed that many of the associations found
by GWAS are due to ‘synthetic associations’ between very
rare variants and less rare alleles, such as SNP markers
(Dickson et al. 2010) on the basis that what is usually
tested are not the causative genes but SNP markers around
them. Under this hypothesis, we believe mTDTP may have
less power than mTDT if we consider results from our
simulations (Fig. 7 and supplementary Figures S55–S59):
using usual mutation frequencies in common diseases
(interval [0.2, 0.4]) mTDTP outperforms mTDT in power; if
we reduce mutation frequencies to be in the interval
[0.1, 0.2], still high to be considered a rare variant, dif-
ferences in power between the two test converge and even
mTDT outperforms mTDTP under several scenarios.
Our ultimate goal is to have a multimarker test that: (1)
requires little computational time, as mTDT or mTDTHE; (2)
provides high power under very different circumstances, as
mTDT or mTDT1T; (3) performs stronger ﬁltering than state-
of-the-art TDTs so that it can detect association in narrower
regions when used as a ﬁrst genome-wide step in searching
for disease susceptibility or protective genes. mTDTP
achieves these three goals better than all the other tests we
used. Moreover, by producing highly informative Com-
parative TDT (CTDT) maps using different low-complexity
TDT measures with very different speciﬁcity and sensitivity
behaviors and using IHMP samples as both control and test
validators, we provide a robust tool for visual exploration
that may assist molecular biologists in decisions about the
regions to choose for ﬁne mapping.
In conclusion, we believe mTDTP can beneﬁt genome-
wideassociationstudiesasitshigherlocusspeciﬁcitymaybe
crucial to improve chances of detecting only associations
close to a disease susceptibility or protective locus and
thereforeitschancesofbeingreplicatedindifferentsamples.
Web source
A supplementary website has been created for this study at
http://bios.ugr.es/TDTP, where Figures S1–S43, Table S1,
a detailed explanation of the simulations performed and the
source code in c?? of the software developed for this
work are available.
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Appendix 1: Variance of mTDTP
The variance of mTDTP can be obtained using a slight
modiﬁcation of the procedure used by Sham (1997) for the
variance of mTDT.
Let Nij be the count for heterozygotic parents with hap-
lotypes i, j transmitting haplotype i to their child, and Nji the
count for parents with the same genotype but transmitting
haplotype j to their child. Let nii be the count for homo-
zygotic parents for haplotype i. Let nij be Nij ? Nji. Con-
sider Nij as a realization of the random variable Xij,
i = 1,…, k, j = i ? 1,…, k, Nji as a realization of the
random variable Xji and Nii as a realization of the random
variable Xii. Thus, Xji = Nij - Xij holds. The counts niT
and niU in mTDTP are then realizations of the random
variables
XiT ¼
X k
j¼1
Xij   Xii
and
XiU ¼
X k
j¼1
Xji   Xii:
Moreover, ni = niT ? niU and n is the total count
haplotype count for heterozygotic parents: n ¼
Pk
i¼1 ni.
The variance of mTDTP is therefore:
VðmTDTPÞ¼Var
X
i¼1
k
XiT þ XiU
n
Yi
"#
;
with Yi deﬁned as:
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123Yi ¼
ðXiT   XiUÞ
2
XiT þ XiU
¼
P
j¼i 2Xij   ni
hi 2
ni
:
As shown by Sham (1997), under the null hypothesis of
no linkage, Yi is v2
1 and
CovðYi;YjÞ¼Cov
n2
ij
ninj
Var
ð2Xij ijÞ
2
nij
"#
¼
2n2
ij
ninj
:
Therefore, the variance of mTDTP is:
VðmTDTPÞ¼
X k
i¼1
ni
n
   2
VarðYiÞþ
X
j6¼i
CovðYi;YjÞ
"#
¼ 2
X k
i¼1
ni
n
   2
þ2
X k
i¼1
ni
n
   2X
j6¼i
n2
ij
ninj
:
Appendix 2: Corrections to the small data problem
There is a well-known condition that must hold for a v
2
test to be appropriately used as a test of independence: the
expected value for each level of the variable cannot be
very low. For mTDT this means that no haplotype count
can be less than 10. In haplotype populations this is an
important issue for haplotypes of a few SNP in length, as
there are usually many rare haplotypes in a sample. The
problem remains when a permutation test is used instead
of the v
2, as the deﬁnition of the measure does not
change. Thus, an upward bias for association cannot be
avoided owing to the high variances for low-frequency
haplotypes. To the best of our knowledge, the conse-
quences of using multimarker mTDT for a small number
of data, which is a very common problem, have not been
studied. The most widely used solution is to disregard
haplotypes with a total count of less than 10 (Sham and
Curtis 1995).
In the present study we considered two different
approaches to the problem of small numbers of data for
mTDT instead of disregarding low-count haplotypes. The
ﬁrst is based on the Yates (1934) correction and the second
on the Laplace correction. It should be noted that all these
corrections improve locus speciﬁcity at a cost of power.
Therefore, when used for loci very close to the disease
susceptibility locus (recombination rates close to 0) dif-
ferences between transmitted and non-transmitted haplo-
types, which are mainly due to true effects, will also be
reduced.
One method for solving the problem of small numbers
of data in v
2 distributions is the Yates (1934) correction,
which is straightforward to apply to mTDT, i.e., small
numbers of data for low-frequency haplotypes, so that the
new test mTDTY is deﬁned as:
mTDTY ¼
k   1
k
X k
i¼1
½jniT   niUj y 
2
niT þ niU
;
with y = 0.5.
The aim of subtracting 0.5 is to reduce the random
effect of very low-frequency haplotypes. However, when
analyzing positions close to a disease susceptibility locus,
most differences between transmitted and non-transmitted
haplotype counts will be due to a true effect and the cor-
rection will lead to a power reduction. A straightforward
generalization of mTDTY is that in which y can be any
value. Changing y by values greater than 0.5 will reduce
the effect of random errors to a greater degree in the case of
very low-frequency haplotypes. However, the power will
also decrease to a greater extent. We denote the statistic for
which y = 1a smTDTY1.
Instead of a constant reduction in the module, a reduc-
tion proportional to the haplotype frequency seems to be a
better choice to yield a higher correction for less frequent
haplotypes. Based on this idea, we deﬁne mTDTYP as:
mTDTYP ¼
k   1
k
X k
i¼1
½jniT   niUj 1=ð2   niÞ 
2
niT þ niU
The correction is the same as TDTY for haplotypes with a
frequency of 1 and is lower for more frequent haplotypes,
with very little effect for high haplotype frequencies.
The correction may outperform TDTY1 in terms of locus
speciﬁcity because it yields greater correction for haplo-
types with lower frequencies. However, the correction may
lead to a higher power reduction because, even for low-
frequency haplotypes, differences between transmitted and
non-transmitted haplotype counts when markers are very
close to the disease susceptibility locus may be due to true
effects.
Another way to proceed instead of reducing the
numerator of each summand is to increase the denominator
of each summand using the Laplace correction, which adds
a constant value f to the count of each haplotype, yielding:
mTDTL ¼
k   1
k
X k
i¼1
ðniT þ f   niU   fÞ
2
niT þ niU þ 2f
¼
k   1
k
X k
i¼1
ðniT   niUÞ
2
niT þ niU þ 2f
:
Here we used f = 1 and f = 2( mTDTL1 and mTDTL2,
respectively).
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